NUCRYST Pharmaceuticals Corp. (WEDX) Announces Completion of Amalgamation
2/9/2010 9:27:19 AM
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX) Announces Distribution of Supplemental Information In Connection with Special Meeting of Shareholders
1/19/2010 9:19:49 AM
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX) Announces Further Adjournment of Special Shareholder Meeting
1/4/2010 8:30:44 AM
More...
|
Smith & Nephew Inc. Completes Acquisition of the Assets of NUCRYST Pharmaceuticals Corp. (WEDX)
12/23/2009 7:11:11 AM
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX) Announces Agreement to Sell Acticoat Business and Proposes Amalgamation with Westaim Corporation for $21 Million
11/11/2009 6:40:09 AM
More...
|
European Launch of Acticoat(TM) Flex with NUCRYST Pharmaceuticals Corp. (WEDX)'s Nanocrystalline Silver Technology Announced by Smith & Nephew Inc.
9/3/2009 11:52:09 AM
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX) Announces 2009 Second Quarter Financial Results
8/5/2009 9:21:41 AM
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX)'s New ACTICOAT(TM) Silver Coated Anti-microbial Barrier Dressing Receives 510(k) Clearance from the US FDA
7/29/2009 7:57:13 AM
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX) Conference Call to Discuss 2009 Second Quarter Results
7/22/2009 9:52:05 AM
More...
|
NUCRYST Pharmaceuticals Corp. (WEDX) Announces 2009 First Quarter Financial Results
5/6/2009 9:04:26 AM
More...
|
|